Results 141 to 150 of about 52,744 (222)

Perioperative Camrelizumab and Apatinib for High‐Risk Resectable Hepatocellular Carcinoma: A Phase II Study

MedComm, Volume 7, Issue 10, October 2026.
In this study, perioperative camrelizumab plus apatinib demonstrated promising efficacy and safety in resectable hepatocellular carcinoma (HCC) patients at high risk of recurrence, achieving a major pathological response of 46.2%. The median disease‐free survival and progression‐free survival were 24.1 months and 18.3 months, respectively.
Yunlong Cui, Xu Bao, Ge Yu, Feng Fang, Qiang Li, Han Mu, Chen Liu, Qiang Wu, Wei Zhang, Huikai Li, Ping Chen, Xiaomeng Liu, Hongyuan Zhou, Tianqiang Song   +13 more
wiley   +1 more source

Exploring the Value of Quantitative Muscle Ultrasound in Neuromuscular Junction Disorders: A Pilot Study

Muscle &Nerve, Volume 74, Issue 4, Page 1281-1287, October 2026.
ABSTRACT Introduction/Aims Quantitative muscle ultrasound (QMUS) is a validated technique for assessing muscle pathology, yet its role in disorders primarily affecting the neuromuscular junction (NMJ) remains unclear. This pilot study aimed to explore whether QMUS is associated with structural muscle changes in patients with acquired or genetic NMJ ...
Artor Pogosean, Maarika Liik, Nens van Alfen, Anna Rostedt Punga   +3 more
wiley   +1 more source

Impact of a 12‐Element Nurse‐Led Tracheostomy Care Bundle on Stoma Integrity, Respiratory Distress and Suspected Pneumonia‐Related Outcomes Among Patients With Tracheostomies: A Quasi‐Experimental Study

Nursing Open, Volume 13, Issue 10, October 2026.
ABSTRACT Aim To evaluate the impact of a 12‐element nurse‐led tracheostomy care bundle, compared with routine care, on stoma integrity, respiratory distress, and pneumonia‐related outcomes among patients with tracheostomies. Design A quasi‐experimental study was conducted among 80 critically ill patients with tracheostomies admitted to Mansoura ...
Eman Yasser Hammouda, Mohammed Elsayed Zaky, Mona Saad Abdelwareth Ahmed, Walaa El‐Khanany Zahran, Hend El‐Sayed Mansour   +4 more
wiley   +1 more source

Complement activation in immune thrombotic thrombocytopenic purpura: Possible amplifier and potential therapeutic opportunity

HemaSphere, Volume 10, Issue 10, October 2026.
Massimo Cugno, Spero R. Cataland, Bernhard Lämmle   +2 more
wiley   +1 more source

Post‐Extubation Recall of Thirst During Mechanical Ventilation Among Intensive Care Unit Patients: A Conventional Content Analysis

Nursing Open, Volume 13, Issue 10, October 2026.
ABSTRACT Background and Aim In ICU patients, particularly after extubation, thirst is a common and troubling symptom. Although earlier research has focused mainly on quantifying thirst severity and its clinical correlates, less is known about the subjective experiences of patients, including their emotional responses, sense of helplessness, help ...
Alireza Sadeghi, Amir Mohamad Nazari, Alun C. Jackson, Elham Khedmati, Fatemeh Bahramnezhad   +4 more
wiley   +1 more source

Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics

Frontiers in Immunology
Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Peng Liu, Peng Liu, Peng Liu, Peng Liu, Guoyan Qi, Guoyan Qi, Guoyan Qi, Guoyan Qi   +11 more
doaj   +1 more source

Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis. [PDF]

Int J Mol Sci
Tian X, Zhang P.
europepmc   +1 more source

Myasthenia gravis: Saccadic eye movement waveforms

, 1980
Myasthenia gravis: Saccadic eye movement ...
D Schmidt (13478410), RB Daropf (15808373), LF Dell'Osso (14464494), Larry Abel (13056207)   +3 more
core  

Immunoglobulin a Deficiency in Coeliac Disease: A Scoping Review

United European Gastroenterology Journal, Volume 14, Issue 8, October 2026.
ABSTRACT Coeliac disease (CeD) and immunoglobulin A deficiency (IgAD) frequently co‐occur and share a genetic background within the HLA‐DQ2 region. Although this has been known for decades, the underlying mechanisms linking the two conditions remain unclear.
Kristine Bech, Cæcilie Crawley, Rok Seon Choung, Joseph A. Murray, Steffen Husby   +4 more
wiley   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

BJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan, Ethan Senior, Jessica Kendall, Jamie B. Oughton, Fiona Collinson, Jon Griffin, Rachel Hubbard, Steven Kennish, Aidan Noon, Derek J. Rosario, Irbaz B. Riaz, Julie Telliez, James W. F. Catto, Syed A. Hussain   +13 more
wiley   +1 more source